Awards & Advancement

Amplyx appoints Ciara Kennedy president and chief executive officer

Monday, January 9, 2017

Amplyx Pharmaceuticals, a company developing novel antifungal agents for life-threatening fungal infections, has announced the appointments of Ciara Kennedy, Ph.D., to president and chief executive officer (CEO) and Karen Joy Shaw, Ph.D., to chief scientific officer (CSO). In conjunction with this announcement, the company’s former president and CEO, Mike Grey, has assumed the role of executive chairman of the Amplyx board of directors. 

[Read More]

Foundation Medicine appoints Troy Cox CEO

Monday, January 9, 2017

Foundation Medicine has announced that, as part of the succession of its executive leadership, the board of directors has appointed Troy Cox, a highly regarded global biopharma leader, as chief executive officer to succeed Michael Pellini, M.D. Dr. Pellini, who has served as chief executive officer of the company since 2011, has been appointed chairman of the company’s board of directors. Alexis Borisy, founding chief executive officer and current chairman of the board for Foundation Medicine, will continue to serve on the board of directors. Cox will also join the board of directors. All of these changes will become effective by February 6, 2017.

[Read More]

Innovus Pharma adds Randy Berholtz as EVP, Corporate Development and General Counsel

Monday, January 9, 2017

Innovus Pharmaceuticals, an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, has announced that Randy Berholtz will join the management team as executive vice president, Corporate Development and General Counsel. A life sciences business and legal veteran with decades of experience, Berholtz joins Innovus Pharma to expand its corporate development efforts to find and enter into additional collaborations to expand the breadth and depth of product offerings on a worldwide basis.

[Read More]

Flagship Pioneering appoints David Epstein executive partner

Thursday, January 5, 2017

Flagship Pioneering has announced the appointment of industry veteran David Epstein to serve in the newly created role of executive partner. Epstein will join as a strategic resource to the firm that systematically conceives, creates, resources and grows first-in-category ventures to transform human health and sustainability. The appointment follows Flagship’s recent additions of industry leaders Dr. Michael Rosenblatt (formerly of Merck) as chief medical officer and Jim Gilbert (formerly of Boston Scientific and Bain) as senior partner, and supports the firm’s goal of driving accelerated value growth within its portfolio companies.

[Read More]

Alessandro Riva to join Gilead as SVP for hematology and oncology

Thursday, January 5, 2017

Gilead Sciences has announced that Alessandro Riva, M.D., will join the company as senior vice president, Hematology and Oncology Therapeutic Area Head. In this position, Dr. Riva will report to John McHutchison, M.D., executive vice president, Clinical Research, and will have responsibility for Gilead’s hematology and oncology programs. Alessandro will also join Gilead’s Executive Committee.

[Read More]

Ironwood Pharmaceuticals adds Amy Schulman to board of directors

Thursday, January 5, 2017

Ironwood Pharmaceuticals has announced the appointment of Amy Schulman to its board of directors. Schulman is an accomplished leader and entrepreneur with a proven track record of enabling pharmaceutical and biotechnology companies to maximize the value of their brands and realize the potential of their innovations. She currently holds key leadership roles at two biotech companies, serving as chief executive officer and co-founder of Lyndra and executive chair of SQZ Biotech. In addition, she is a venture partner at Polaris Partners, serving on the firm’s life sciences investment team.

[Read More]

Illumina hires Garret Hampton to head Clinical Genomics Unit

Tuesday, January 3, 2017

Illumina, continuing its strategy to bring the power of genomics into clinical applications, has named one of the world’s top clinical genomics experts to head its clinical genomics unit. Garret Hampton, Ph.D., will join as executive vice president of Clinical Genomics for the company, starting January 9, 2017.

[Read More]

GeoVax forms scientific advisory board

Tuesday, January 3, 2017

GeoVax Labs, a biotechnology company specializing in developing human vaccines, has announced the formation of its inaugural Scientific Advisory Board (SAB) to provide expert guidance as the company advances its vaccine development for multiple targets including HIV, hemorrhagic fever (Ebola, Sudan, Marburg, Lassa), Zika virus, chronic Hepatitis B and immuno-oncology.

[Read More]